Did Kim Kardashian Use Miracle Fat-Fighting Drug?
Did Kim Kardashian Use Miracle Fat-Fighting Drug?

Did Kim Kardashian Use Miracle Fat-Fighting Drug? Read article to know what helped Kim Kardashian loose weight in three weeks.

 

Did Kim Kardashian Use Miracle Fat-Fighting Drug?

Semaglutide — a Miracle Fat-Fighting Drug sold under the brand name Ozempic or Wegovy — suppresses appetite, helping people lose nearly a fifth of their weight. It was hailed as a major breakthrough when it burst onto the scene last year.

Hollywood actresses are rumored to be using the injections to stay as skinny as possible.

Even Elon Musk has attributed his recent weight loss to the medication.

Social media is also replete with rumors that Use utilized the medicine to shed more than a stone in just three weeks.

According to experts, the drug’s extraordinary success has sparked a TikTok-fueled rush, with stocks suddenly surging all over the globe.

The export of semaglutide has now been prohibited by ministers. All available supplies of these medications must be used in the UK to satisfy demand, so they cannot be exported.

Similar situations occurred during the HRT crisis when medications to treat menopause were in short supply, and during the early stages of the pandemic, when supplies of medications for intensive care were stored in the UK.

In May, reality TV star Kim Kardashian told Vogue magazine she had lost 16 lb in three weeks so she would be thin enough to fit into a dress that once belonged to Marilyn Monroe, rumours began to circulate that she had used semaglutide

In May, reality TV star Kim Kardashian (left) told Vogue magazine she had lost 16 lb in three weeks so she would be thin enough to fit into a dress that once belonged to Marilyn Monroe, rumours began to circulate that she had used semaglutide.

Semaglutide — a jab sold under the brand name Ozempic or Wegovy (pictured) — suppresses appetite, helping people lose a fifth of their weight. It was hailed as a major breakthrough when it burst onto the scene last year

Semaglutide — a jab sold under the brand name Ozempic or Wegovy (pictured) — suppresses appetite, helping people lose a fifth of their weight. It was hailed as a major breakthrough when it burst onto the scene last year

WHAT IS WEGOVY?

Wegovy is the brand name for a drug called semaglutide.

Semaglutide with a dose of 1 mg has already received approval in the UK for the treatment of type 2 diabetes.

However, research has shown that 2.4 mg of the medicine is helpful for weight loss.

It functions by inducing the body to make glucagon-like peptide-1, a hormone that is ordinarily released from the intestines after meals.

The hormone makes people feel full so they know when to stop eating and helps regulate blood sugar.

Results of a study involving 2,000 people over a period of 15 months reveal that participants on average lost 15% of their body weight, or 15.3 kg.

Along with the weekly injections, the group received individualized counseling from qualified dietitians to assist them follow a low-calorie diet and activity plan.

The volunteers’ quality of life had improved, and their risk factors for diabetes and heart disease had decreased, including their waist circumference, blood fat levels, blood sugar, and blood pressure.

However, the medicine also caused mild to moderate diarrhoea and nausea, but researchers stated these side effects were transient and went away on their own.

The drug’s producer, Novo Nordisk UK, claimed that it had faced “record demand.”

The Department of Health has taken action to outlaw what is referred to as the parallel export of medicines. This means that wholesalers cannot purchase UK inventories with the intention of exporting them.

The NHS spending watchdog NICE approved the jab — taken once a week via an EpiPen-like device — for obese patients earlier this year.

It was off the back of a study which showed that obese people who took the drug, alongside eating less and exercising more, lost 15 per cent of their body weight. For comparison, the group who just led a healthier lifestyle lost just two per cent of their body weight.

Wegovy, which is set to become available in late 2022 or early 2023, will be offered to morbidly obese people who have at least one weight-related health condition.

If they are recommended by their doctor, obese people may also be able to receive the medication.

Specialists may lawfully recommend semaglutide to anyone they believe would benefit, a practice known as “off-label” use, even though it is only legally permitted for use in obese individuals who are also experiencing health issues. It has made it possible for clinicians to preventatively prescribe semaglutide to high-risk patients rather than waiting for them to become unwell.

Semaglutide functions by imitating the hormone glucagon-like peptide-1 (GLP-1), which is released after meals.

In order to help move digested sugar from the blood into cells where it can be used for energy, the body is signaled to release insulin.

This causes feelings of satiety.

Patients taking the drug claim to have been left repulsed by their own favourite food — including coffee, chocolate and fried chicken.

Other GLP-1 agonists, like they are known, are available, including dulaglutide and liraglutide.

Pharmacists say shortages are now affecting these, too. Yet they are not on the Government’s export ban.

Leyla Hannbeck, of the Association of Independent Multiple Pharmacists, told The Mail on Sunday: ‘There has been a problem getting hold of all GLP-1 agonists for a few months now – particularly semaglutide.

‘It is similar to what happened with HRT – people post about the benefits on social media and suddenly everyone wants to take it.’

The demand is thought to have been sparked, partly, by Kim Kardashian’s weight loss in May 2022, when she lost 16lbs (7.3kg) to fit into Marilyn Monroe’s old dress.

Kim never commented on rumours that she used the drug, which became rife on social media.

In one TikTok clip, viewed more than 1million times, an evangelical patient speculates: ‘In my opinion Kim’s drastic weight loss could be due to something like [semaglutide]… I might be wrong.

These medications are instruments that enable people to entirely alter their bodies’ metabolisms.

In September of this year, the US entertainment magazine Variety stated: “Celebrity styling teams have come to embrace the injections as part of grooming regimens.

It has turned into Hollywood’s worst-kept secret.

Elon Musk gave “fasting” and “Wegovy” the credit for his 30lb (13.6kg) weight loss when asked if eating better or working out were the causes.

Despite becoming more and more popular among celebrities, studies have shown that the medication can cause constipation, a sore stomach, mild to moderate nausea, and mild to moderate diarrhoea.

Researchers note that these are self-resolving and transient.

You May Also Like

Outshine Smoothie Cubes Are Convenience In a Cup

In theory, whipping together a quick heart-healthy smoothie before you head to…

Why a Derm and a Dietician Recommend Kimchi for Eczema

On a recent trip to Seoul, I made sure to squeeze some…

These Heart Symptoms, Including Swelling, Can Appear Early. Catch Them Fast to Live a Longer Life. 

Heart disease remains the leading cause of death in the United States and…

Signs You May Have Already Had COVID, Says CDC, Including Fatigue

The holiday season is here and so are three viruses–COVID, influenza and…

I'm a Doctor and Here's How to Tell If You May Have Dementia

The early signs of dementia can be so vague they’re often overlooked…

The Benefits of Napping Every Day, Expert Reveals

Every cold, rainy, gloomy day should include a cozy nap, don’t you…

Does Everyone Have Wisdom Teeth? Everything You Need to Know — Credihealth Blog

If you’re like most people, you probably haven’t given your wisdom teeth…

4 Biggest Complaints Costco Customers Are Voicing Right Now

If you’re looking for a one-stop shopping destination, it’s hard to find…